BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21551128)

  • 1. Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice.
    Kovtun IV; Harris KJ; Jatoi A; Jevremovic D
    Carcinogenesis; 2011 Jul; 32(7):1085-92. PubMed ID: 21551128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate mutator genes in mismatch repair-deficient thymic lymphomas: no evidence of mutations in the DNA polymerase delta gene.
    Campbell MR; Thang TY; Jirik FR; Andrew SE
    Carcinogenesis; 2000 Dec; 21(12):2281-5. PubMed ID: 11133819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
    Jin W; Wang LQ; Liu Y; Liu AJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
    [No Abstract]   [Full Text] [Related]  

  • 4. Mouse models for hereditary nonpolyposis colorectal cancer.
    de Wind N; Dekker M; van Rossum A; van der Valk M; te Riele H
    Cancer Res; 1998 Jan; 58(2):248-55. PubMed ID: 9443401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.
    Wojciechowicz K; Cantelli E; Van Gerwen B; Plug M; Van Der Wal A; Delzenne-Goette E; Song JY; De Vries S; Dekker M; Te Riele H
    Gastroenterology; 2014 Nov; 147(5):1064-72.e5. PubMed ID: 25088490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Msh2 deficiency increases susceptibility to benzo[a]pyrene-induced lymphomagenesis.
    Zienolddiny S; Ryberg D; Svendsrud DH; Eilertsen E; Skaug V; Hewer A; Phillips DH; te Riele H; Haugen A
    Int J Cancer; 2006 Jun; 118(11):2899-902. PubMed ID: 16381012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable MLH1 promoter methylation patterns in endometrial carcinomas of endometrioid subtype lacking DNA mismatch repair.
    Helmle KE; Otto CJ; Constantinescu G; Honore LH; Andrew SE
    Int J Gynecol Cancer; 2005; 15(6):1089-96. PubMed ID: 16343186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent CTNNB1 or PIK3CA Mutations Occurred in Endometrial Endometrioid Adenocarcinoma With High Levels of Microsatellite Instability and Loss of MSH2/MSH6 Expression.
    Huang HN; Kuo CW; Lin MC; Mao TL; Kuo KT
    Appl Immunohistochem Mol Morphol; 2020 Apr; 28(4):284-289. PubMed ID: 30789355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions.
    de Wind N; Dekker M; Claij N; Jansen L; van Klink Y; Radman M; Riggins G; van der Valk M; van't Wout K; te Riele H
    Nat Genet; 1999 Nov; 23(3):359-62. PubMed ID: 10545954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
    Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mismatch repair proteins, beta catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma.
    Perez-Ordonez B; Huynh NN; Berean KW; Jordan RC
    J Clin Pathol; 2004 Oct; 57(10):1080-3. PubMed ID: 15452164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis.
    Russo MT; De Luca G; Casorelli I; Degan P; Molatore S; Barone F; Mazzei F; Pannellini T; Musiani P; Bignami M
    Cancer Res; 2009 May; 69(10):4372-9. PubMed ID: 19435918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex SNaPshot genotyping for detecting loss of heterozygosity in the mismatch-repair genes MLH1 and MSH2 in microsatellite-unstable tumors.
    Bujalkova M; Zavodna K; Krivulcik T; Ilencikova D; Wolf B; Kovac M; Karner-Hanusch J; Heinimann K; Marra G; Jiricny J; Bartosova Z
    Clin Chem; 2008 Nov; 54(11):1844-54. PubMed ID: 18772310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts.
    Andrew SE; Xu XS; Baross-Francis A; Narayanan L; Milhausen K; Liskay RM; Jirik FR; Glazer PM
    Carcinogenesis; 2000 Jul; 21(7):1291-5. PubMed ID: 10874005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic lymphomas arising in Msh2 deficient mice display a large increase in mutation frequency and an altered mutational spectrum.
    Zhang S; Lloyd R; Bowden G; Glickman BW; de Boer JG
    Mutat Res; 2002 Mar; 500(1-2):67-74. PubMed ID: 11890935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.
    Kucherlapati MH; Lee K; Nguyen AA; Clark AB; Hou H; Rosulek A; Li H; Yang K; Fan K; Lipkin M; Bronson RT; Jelicks L; Kunkel TA; Kucherlapati R; Edelmann W
    Gastroenterology; 2010 Mar; 138(3):993-1002.e1. PubMed ID: 19931261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.
    Claij N; van der Wal A; Dekker M; Jansen L; te Riele H
    Cancer Res; 2003 May; 63(9):2062-6. PubMed ID: 12727820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
    Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
    Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of Msh2 knockdown on methylating agent induced toxicity in DNA glycosylase deficient cells.
    Cooley N; Elder RH; Povey AC
    Toxicology; 2010 Jan; 268(1-2):111-7. PubMed ID: 20025921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.